Bio-Techne (TECH) Depreciation & Amortization (CF) (2009 - 2026)

Bio-Techne's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $24.2 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 12.34% year-over-year to $24.2 million; the TTM figure through Mar 2026 stood at $100.3 million (down 9.49% YoY), while the FY2025 annual figure was $109.9 million, down 1.62% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $24.2 million, down from $24.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $28.5 million in Q3 2023, with the low at $24.2 million in Q1 2026.
• The 5-year median for Depreciation & Amortization (CF) is $27.0 million (2023), against an average of $26.7 million.
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) climbed 20.21% in 2022, then decreased 13.49% in 2025.
• Bio-Techne's Depreciation & Amortization (CF) stood at $26.7 million in 2022, then grew by 4.12% to $27.8 million in 2023, then dropped by 2.59% to $27.1 million in 2024, then retreated by 8.77% to $24.7 million in 2025, then retreated by 2.19% to $24.2 million in 2026.
• Business Quant data shows TECH's Depreciation & Amortization (CF) at $24.2 million in Q1 2026, $24.7 million in Q4 2025, and $24.3 million in Q3 2025.